STOCK TITAN

Octave Specialty Group Inc Financials

OSG
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Octave Specialty Group Inc (OSG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OSG FY2025

A shrunken balance sheet now supports similar sales, but the business still fails to turn activity into cash.

Between FY2024 and FY2025, total assets fell 72.4% while total liabilities fell 83.4%. Yet revenue still reached $251.2M and operating cash flow turned to -$52.3M, implying the balance-sheet reset improved solvency faster than the core business improved self-funding.

By FY2025, long-term debt was only $117.6M against $70.1M of cash, a much lighter financing posture than earlier in the series. But goodwill of $540.3M sits against equity of $715.8M, so a large share of book value is tied to non-cash assets rather than immediate liquidity.

Overhead intensity looks like the current operating choke point: SG&A consumed $191.6M against revenue of $251.2M in FY2025. That helps explain why losses persisted even though interest expense was only $18.6M and the net loss narrowed to -$259M; the strain appears more operational than balance-sheet-driven.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 33 / 100
Financial Profile 33/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Octave Specialty Group Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
100

Octave Specialty Group Inc's revenue grew 6.5% year-over-year to $251.2M, a solid pace of expansion. This earns a growth score of 100/100.

Leverage
99

Octave Specialty Group Inc carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Returns
0

Octave Specialty Group Inc generates a -36.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -69.6% the prior year.

Piotroski F-Score Weak
3/9

Octave Specialty Group Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.20x

For every $1 of reported earnings, Octave Specialty Group Inc generates $0.20 in operating cash flow (-$52.3M OCF vs -$259.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$251.2M
YoY+6.5%
5Y CAGR+10.0%
10Y CAGR-9.6%

Octave Specialty Group Inc generated $251.2M in revenue in fiscal year 2025. This represents an increase of 6.5% from the prior year.

EBITDA
N/A
Net Income
-$259.0M
YoY+53.4%

Octave Specialty Group Inc reported -$259.0M in net income in fiscal year 2025. This represents an increase of 53.4% from the prior year.

EPS (Diluted)
$-5.93
YoY+50.4%

Octave Specialty Group Inc earned $-5.93 per diluted share (EPS) in fiscal year 2025. This represents an increase of 50.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$70.1M
YoY+136.7%
5Y CAGR+28.5%
10Y CAGR+4.8%

Octave Specialty Group Inc held $70.1M in cash against $117.6M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
45M
YoY-3.2%
5Y CAGR-0.4%
10Y CAGR-17.5%

Octave Specialty Group Inc had 45M shares outstanding in fiscal year 2025. This represents a decrease of 3.2% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
-103.1%
YoY+132.7pp
5Y CAGR+177.0pp
10Y CAGR-65.7pp

Octave Specialty Group Inc's net profit margin was -103.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 132.7 percentage points from the prior year.

Return on Equity
-36.2%
YoY+33.5pp
5Y CAGR+4.3pp

Octave Specialty Group Inc's ROE was -36.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 33.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$29.9M
YoY+156.0%

Octave Specialty Group Inc spent $29.9M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 156.0% from the prior year.

Capital Expenditures
N/A

OSG Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $66.9M+0.4% $66.6M+21.2% $55.0M-12.4% $62.8M-3.8% $65.2M-6.8% $70.0M+37.2% $51.0M+3.0% $49.6M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $58.8M+9.6% $53.7M+32.5% $40.5M+5.2% $38.5M-4.7% $40.4M-8.1% $44.0M+57.9% $27.9M+58.5% $17.6M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $1.4M-76.9% $6.2M+11.0% $5.6M+2.1% $5.5M+120.5% -$26.6M-233.1% $20.0M+25.0% $16.0M $0
Income Tax $9.2M+844.6% -$1.2M+42.9% -$2.2M-252.0% -$617K-136.5% $1.7M+295.0% -$867K-2790.0% -$30K-123.1% $130K
Net Income -$28.9M+74.3% -$112.6M-54.9% -$72.7M-62.5% -$44.7M+91.8% -$548.3M-1893.5% -$27.5M-3567.1% -$750K-103.6% $20.8M
EPS (Diluted) N/A $-2.35-52.6% $-1.54-26.2% $-1.22+88.1% $-10.23-1523.8% $-0.63-3050.0% $-0.02-104.5% $0.44

OSG Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $2.2B+3.5% $2.1B-74.8% $8.5B+3.3% $8.3B+2.4% $8.1B-12.9% $9.3B+13.1% $8.2B-2.9% $8.4B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $70.1M+154.7% $27.5M+22.1% $22.5M-33.8% $34.1M+15.1% $29.6M-27.4% $40.8M+179.7% $14.6M+6.1% $13.8M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $540.3M+21.3% $445.4M-1.4% $451.8M+5.2% $429.3M+2.6% $418.2M-3.6% $434.0M+520.0% $70.0M0.0% $70.0M
Total Liabilities $1.1B+13.7% $1.0B-86.3% $7.3B+3.7% $7.0B+2.6% $6.9B-7.0% $7.4B+9.4% $6.7B-3.5% $7.0B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $117.6M+17.6% $100.0M N/A N/A $0-100.0% $518.0M+0.6% $515.0M+0.6% $512.0M
Total Equity $715.8M-15.1% $843.4M-1.9% $859.8M+0.9% $852.2M+6.7% $798.4M-45.5% $1.5B+7.1% $1.4B+0.2% $1.4B
Retained Earnings $370.4M-24.7% $491.7M-19.1% $607.5M-10.8% $681.5M-0.3% $683.6M-44.6% $1.2B-2.4% $1.3B-0.1% $1.3B

OSG Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$666K+98.4% -$41.2M-2015.0% $2.1M+117.0% -$12.6M+83.3% -$75.6M-254.6% $48.9M+139.7% $20.4M+188.6% $7.1M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A $247.3M+7574.8% -$3.3M-115.5% $21.3M N/A -$225.8M-1055.0% -$19.6M-7089.0% -$272K
Financing Cash Flow $232.1M+215.5% -$201.0M-4562.0% -$4.3M+20.7% -$5.4M+96.9% -$178.2M-185.5% $208.6M+52241.0% -$400K+70.0% -$1.3M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

OSG Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin -43.3%+125.8pp -169.1%-36.8pp -132.3%-61.0pp -71.3%+769.3pp -840.6%-801.3pp -39.3%-37.8pp -1.5%-43.4pp 41.9%
Return on Equity -4.0%+9.3pp -13.4%-4.9pp -8.5%-3.2pp -5.3%+63.4pp -68.7%-66.8pp -1.9%-1.8pp -0.1%-1.6pp 1.5%
Return on Assets -1.3%+3.9pp -5.2%-4.4pp -0.9%-0.3pp -0.5%+6.3pp -6.8%-6.5pp -0.3%-0.3pp -0.0%-0.3pp 0.3%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.16+0.0 0.12-8.4 8.49+0.2 8.26+8.3 0.00-0.4 0.35-0.0 0.380.0 0.38
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

Octave Specialty Group Inc (OSG) reported $251.2M in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Octave Specialty Group Inc (OSG) revenue grew by 6.5% year-over-year, from $235.8M to $251.2M in fiscal year 2025.

No, Octave Specialty Group Inc (OSG) reported a net income of -$259.0M in fiscal year 2025, with a net profit margin of -103.1%.

Octave Specialty Group Inc (OSG) reported diluted earnings per share of $-5.93 for fiscal year 2025. This represents a 50.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Octave Specialty Group Inc (OSG) had $70.1M in cash and equivalents against $117.6M in long-term debt.

Octave Specialty Group Inc (OSG) had a net profit margin of -103.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Octave Specialty Group Inc (OSG) has a return on equity of -36.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Octave Specialty Group Inc (OSG) generated -$52.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Octave Specialty Group Inc (OSG) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Octave Specialty Group Inc (OSG) spent $29.9M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Octave Specialty Group Inc (OSG) had 45M shares outstanding as of fiscal year 2025.

Octave Specialty Group Inc (OSG) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Octave Specialty Group Inc (OSG) had a return on assets of -11.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Octave Specialty Group Inc (OSG) had $70.1M in cash against an annual operating cash burn of $52.3M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Octave Specialty Group Inc (OSG) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Octave Specialty Group Inc (OSG) has an earnings quality ratio of 0.20x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Octave Specialty Group Inc (OSG) scores 33 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top